NLRP3 inflammasome is activated in fibromyalgia: The effect of coenzyme Q10

Antioxidants and Redox Signaling

Volumn 20, Issue 8, 2014, Pages 1169-1180

  Cordero, Mario D ^a   Alcocer Gómez, Elísabet ^a   Culic, Ognjen ^b   Carrión, Angel M ^c   De Miguel, Manuel ^a   Díaz Parrado, Eduardo ^a   Pérez Villegas, Eva M ^c   Bullón, Pedro ^d   Battino, Maurizio ^e   Sánchez Alcazar, José Antonio ^c  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^d UNIVERSITY OF SEVILLE   (Spain)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMALS; CARRIER PROTEINS; CASE-CONTROL STUDIES; CASPASE 1; CELLS, CULTURED; CYTOKINES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENZYME ACTIVATION; FEMALE; FIBROMYALGIA; GENE EXPRESSION; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MICE; MIDDLE AGED; MITOCHONDRIA; OXIDATIVE STRESS; UBIQUINONE; VITAMINS;

EID: 84894451166     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5198     Document Type: Review

References (31)

1. Altindag O and Celik H. Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep 11: 131-135, 2006.
2. Bagis S, Tamer L, Sahin G, Bilgin R, Guler H, Ercan B, and Erdogan C. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 25: 188-190, 2005.
3. Battino M, Fato R, Parenti-Castelli G, and Lenaz G. Coenzyme Q can control the efficiency of oxidative phosphorylation. Int J Tissue React 12: 137-144, 1990.
4. Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Giuliano T, De Feo F, Ciapparelli A, Dell'Osso L, and Bombardieri S. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 25: 225-230, 2007.
5. Cordero MD, Alcocer-Gómez E, Cano-Garc?́a FJ, De Miguel M, Carrión AM, Navas P, and Sánchez Alcázar JA. Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma. PLoS One 6: e26915, 2011.
6. Cordero MD, Alcocer-Gómez E, de Miguel M, Cano-Garc?́a FJ, Luque CM, Fernández-Riejo P, Fernández AM, and Sánchez-Alcazar JA. (Coenzyme Q(10): a novel therapeutic approach for Fibromyalgia? case series with 5 patients. Mitochondrion 11: 623-625, 2011.
7. Cordero MD, De Miguel M, Moreno Fernández AM, Carmona López IM, Garrido Maraver J, Cotán D, Gómez Izquierdo L, Bonal P, Campa F, Bullon P, Navas P, and Sánchez Alcázar JA. Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromialgia patients: implications in the pathogenesis of the disease. Arthritis Res Ther 12: R17, 2011.
8. Cordero MD, D?́az-Parrado E, Carrión AM, Alfonsi S, Sánchez-Alcazar JA, Bullón P, Battino M, and de Miguel M. Is inflammation a mitochondrial dysfunction-dependent event in Fibromyalgia? Antioxid Redox Signal 18: 800-807, 2013.
9. Cordero MD, Moreno-Fernández AM, deMiguel M, Bonal P, Campa F, Jiménez-Jiménez LM, Ruiz-Losada A, Sánchez-Dom?́nguez B, Sánchez Alcázar JA, Salviati L, and Navas P. Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia. Clin Biochem 42: 732-735, 2009.
10. Feng J, Zhang Z, Li W, Shen X, Song W, Yang C, Chang F, Longmate J, Marek C, St Amand RP, Krontiris TG, Shively JE, and Sommer SS. Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels. PLoS One 4: e8480, 2009.
11. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, and Wolfe F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58: 26-35, 2008.
12. Li WW, Guo TZ, Liang D, Shi X, Wei T, Kingery WS, and Clark JD. The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome. Pain 147: 277-286, 2009.
13. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
14. Mabley JG, Pacher P, Deb A, Wallace R, Elder RH, and Szabó C. Potential role for 8-oxoguanine DNA glycosylase in regulating inflammation. FASEB J 19: 290-292, 2005.
15. Menu P and Vince JE. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol 166: 1-15, 2011.
16. Montero R, Sánchez-Alcázar JA, Briones P, Hernández AR, Cordero MD, Trevisson E, Salviati L, Pineda M, Garc?́a-Cazorla A, Navas P, and Artuch R. Analysis of coenzyme Q10 in muscle and fibroblasts for the diagnosis of CoQ10 deficiency syndromes. Clin Biochem 41: 697-700, 2008.
17. Mukhopadhyay P, Rajesh M, Yoshihiro K, Hasko G, and Pacher P. Simple quantitative detection of mitochondrial superoxide production in live cells. Biochem Biophys Res Commun 358: 203-208, 2007.
18. Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, and Yildizhan H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int 26: 598-603, 2006.
19. Piantadosi CA and Suliman HB. Transcriptional control of mitochondrial biogenesis and its interface with inflammatory processes. Biochim Biophys Acta 1820: 532-541, 2012.
20. Quinzii CM, López LC, Von-Moltke J, Naini A, Krishna S, Schuelke M, Salviati L, Navas P, DiMauro S, and Hirano M. Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency. FASEB J 22: 1874-1885, 2008.
21. Rodriguez-Hernandez A, Cordero MD, Salviati L, Artuch R, Pineda M, Briones P, Gómez Izquierdo L, Cotán D, Navas P, and Sánchez-Alcázar JA. Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autophagy 5: 19-32, 2009.
22. Ross RL, Jones KD, Bennett RM, Ward RL, Druker BJ, and Wood LJ. (2010). Preliminary evidence of increased pain and elevated cytokines in fibromyalgia patients with defective growth hormone response to exercise. Open Immunol J 3: 9-18, 2010.
23. Rustin P, Chretien D, Bourgeron T, Gérard B, Rö tig A, Saudubray JM, and Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228: 35-51, 1994.
24. Salemi S, Rethage J, Wollina U, Michel BA, Gay RE, Gay S, and Sprott H. Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J Rheumatol 30: 146-150, 2003.
25. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, Rentsendorj A, Vargas M, Guerrero C, Wang Y, Fitzgerald KA, Underhill DM, Town T, and Arditi M. Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis. Immunity 36: 401-414, 2012.
26. Staud R. Pharmacological treatment of fibromyalgia syndrome: new developments. Drug 70: 1-14, 2010.
27. Turunen M, Olsson J, and Dallner G. Metabolism and function of coenzyme Q. Biochem Biophys Acta 1660: 171-199, 2004.
28. Verri WA, Jr., Cunha TM, Parada CA, Poole S, Liew FY, Ferreira SH, and Cunha FQ. Antigen-induced inflammatory mechanical hypernociception in mice is mediated by IL-18. Brain Behav Immun 21: 535-543, 2007.
29. Wallace DJ. Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des 12: 17-22, 2006.
30. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, and Clark P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33: 160-172, 1990.
31. Zhou R, Yazdi AS, Menu P, and Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225, 2011.